Search Results

Despite the availability of modern tools, Ben stresses the enduring value of classical methods like GTPγS assays , radioligand binding , and basic PK/PD models . Using site-directed mutagenesis and pharmacological synergy assays , his team aims to understand how

His focus is on expanding commercial reach and accelerating the adoption of the company’s GPCR assay Post not marked as liked 4 Fluorescence based HTS compatible ligand binding assays for dopamine D3 receptors Celtarys develops fluorescently labeled ligands designed for real-time, non-radioactive GPCR assays—enabling GPCR Functional Assay Fluorescent GTPγS enables sensitive, non-radioactive GPCR activity assays for drug

During my PhD, I learnt radioligand binding assays, behavioral assays, autoradiography, stereotaxic surgeries

David has over 20+ years of experience working in a drug discovery environment mainly in a specialist assay His current interests include the development of HTS fluorescence-based kinetic binding assays specifically

focus is on enabling fast, customizable development of fluorescent ligands and chemical probes for GPCR assays biotech network, and the company quickly defined its value: building better tools for drug discovery assays GPCR, Celtarys will bring those lessons to the broader community, providing insight into assay development Each probe must retain activity, remain soluble, and be compatible with a given assay format. Whether you're designing assays, developing probes, or seeking better tools for GPCR drug discovery,

Khorana’s lab made early key contributions and developed strategies to express, reconstitute and assay He also went on to discover a “counterion switch” in visual pigments and to develop strategies to assay Howard Hughes Medical Institute appointment, Tom advanced a series of novel biochemical and biophysical assay

GPCR to support assay development worldwide.

GPCR to support assay development worldwide.

He also discussed the evolution of the field, from biochemical radioligand binding assays to cell-based functional assays, and the influence of Terry Kenakin and chemical programs on his later work. They discussed strategies for analyzing large compound screening data, emphasizing robust assays and Arthur recounted a 2004 visit to a pharma company using replicates in assays. conversation highlighted the importance of establishing the correct disease context, setting up appropriate assays

GPCR to support assay development worldwide. ✳️Celtarys is ready to support your assay development. Get to know more: Celtarys Research | Dr. Get custom, fast, and functional ligands backed by real scientists solving real assay problems. 🧪 “We We solve assay problems.” – Dr. By using signalling assays, radioligand binding assay, and microscopy, Gaidarov et al. suggested that

Accelerated Program Progression: Design robust assay cascades and establish key go/no-go points to speed Optimization For Contract Research Organizations Elevate Scientific Offerings: Refine and optimize your GPCR assay Define Actionable Objectives Together, we clarify specific, measurable goals, from target validation and assay Accelerated Preclinical Progression I streamline critical operational processes, from advanced assay Small missteps can derail entire programs: underperforming assays, off-track CROs, and data that fails

Curiosity to Collaboration “We decided to evaluate the multiplexing methods... and found this Luminex assay ” – Tom Sakmar After exploring several screening techniques, the lab adopted the Luminex bead-based assay could accelerate discovery of therapeutic targets by combining multiplex data with focused downstream assays focusing on a single receptor, students now gravitate toward platforms , biosensors , and data-rich assays Keyword Cloud GPCR-RAMP interactions , multiplex assays , GPCR research community , Dr.

MRAP2 regulates GHSR1a signaling; this project brought forth our NanoBiT-based arrestin recruitment assay This powerful tool allowed us to create an assay that kinetically measured the arrestin recruitment to I joined the lab, I became proficient in many In-vivo techniques, I adapted my arrestin recruitment assay

protein-coupled receptor kinase (GRK) – beta-arrestin system, the coordination of heterotrimeric G protein, small GTP-binding

protein-coupled receptor kinase (GRK) – beta-arrestin system, the coordination of heterotrimeric G protein, small GTP-binding

protein-coupled receptor kinase (GRK) – beta-arrestin system, the coordination of heterotrimeric G protein, small GTP-binding

protein-coupled receptor kinase (GRK) – beta-arrestin system, the coordination of heterotrimeric G protein, small GTP-binding

His current work is mainly focused on screening and assay development to bridge the gap between in vitro

There she researched the beta-2 adrenergic receptor and developed assays to investigate real-time activity

the human aGPCRs CD97/ADGRE5 and Latrophilin/ADGRL3 and tested in HEK293T cells using a luciferase assay Tobias Langenhan's group, where I currently manage a project to establish a drug screening assay for In addition, the platform was used to develop assays for high-throughput screening for challenging adhesion

technologies in gene synthesis, DNA information storage, gene editing, and large-scale multiplexed assays

INSERM with a specific interest in G protein-coupled receptors by developing original BRET and TR-FRET assays

Daly at NIH and Solomon Snyder at Johns Hopkins, he developed the first adenosine receptor binding assay

his work on bioluminescence resonance energy transfer (BRET) resulted in the development of screening assays

Her research focuses on the structure and function of GTP binding proteins and the molecular mechanisms

his work on bioluminescence resonance energy transfer (BRET) resulted in the development of screening assays

, to exploit a Ric-8-based technology to purify recombinant G proteins and to use the G proteins in assays

Prioritize assays based on project phase and decision points Map go/no-go logic that guides program momentum they’ll change outcomes No More Strategy Swirl I build structure that sticks—from CRO engagement to assay